Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response
Itziar Cenzano, Miguel Cócera, Marta Larrayoz, Lorea Campos-Dopazo, Sonia Sanz, Azari Bantan, Amaia Vilas-Zornoza, Patxi San-Martin, Paula Aguirre-Ruiz, Diego Alignani, Aitziber Lopez, Ignacio Sancho González, Javier Ruiz, Purificacion Ripalda-Cemborain, Marta Abengozar-Muela, Emma Muiños-López, Vincenzo Lagani, Jesper Tegner, Mikel Hernáez, Xabier Agirre, Benjamin Ebert, Bruno Paiva, Paula Rodriguez-Otero, Luis-Esteban Tamariz-Amador, Jesús San-Miguel, Borja Saez, José A. Martinez-Climent, Isabel A. Calvo, David Gomez-Cabrero, Felipe Prosper · 2026
Read Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response by Itziar Cenzano, Miguel Cócera, Marta Larrayoz, Lorea Campos-Dopazo, Sonia Sanz, Azari Bantan, Amaia Vilas-Zornoza, Patxi San-Martin, Paula Aguirre-Ruiz, Diego Alignani, Aitziber Lopez, Ignacio Sancho González, Javier Ruiz, Purificacion Ripalda-Cemborain, Marta Abengozar-Muela, Emma Muiños-López, Vincenzo Lagani, Jesper Tegner, Mikel Hernáez, Xabier Agirre, Benjamin Ebert, Bruno Paiva, Paula Rodriguez-Otero, Luis-Esteban Tamariz-Amador, Jesús San-Miguel, Borja Saez, José A. Martinez-Climent, Isabel A. Calvo, David Gomez-Cabrero, Felipe Prosper (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13443197.txt.
Description
Itziar Cenzano and colleagues track marrow wall and stem cells as a blood state slides toward myeloma in a 2026 study. The early state, MGUS, can sit quiet for years before cancer blooms. Mouse models that copy the slide gave single-cell reads for vessel lining cells and marrow stem cells.
Lining cells took a stress cast at the MGUS stage, before new vessels sprouted in full cancer. Stem cells lost their bone-making power early, and that loss held through the slide. A joint interferon program marked one model but missed its fiercer twin. A three-drug mix hushed that program, helped lining cells adapt, and revived bone power in stem cells. Patient checks found the same mark enriched across stages.
Catalog record
| CREATOR | Itziar Cenzano, Miguel Cócera, Marta Larrayoz, Lorea Campos-Dopazo, Sonia Sanz, Azari Bantan, Amaia Vilas-Zornoza, Patxi San-Martin, Paula Aguirre-Ruiz, Diego Alignani, Aitziber Lopez, Ignacio Sancho González, Javier Ruiz, Purificacion Ripalda-Cemborain, Marta Abengozar-Muela, Emma Muiños-López, Vincenzo Lagani, Jesper Tegner, Mikel Hernáez, Xabier Agirre, Benjamin Ebert, Bruno Paiva, Paula Rodriguez-Otero, Luis-Esteban Tamariz-Amador, Jesús San-Miguel, Borja Saez, José A. Martinez-Climent, Isabel A. Calvo, David Gomez-Cabrero, Felipe Prosper |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92006 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |